Legal Representation
Attorney
Andrew J. Avsec
USPTO Deadlines 2 active
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
OFFICE ACTION
Non-Final Action E-Mailed |
GNRTF | Sep 18, 2025 | 73 days | Critical | Until Dec 18, 2025 |
OFFICE ACTION
Non-Final Action Mailed |
CNRTR | Sep 18, 2025 | 73 days | Critical | Until Dec 18, 2025 |
Next deadline: Non-Final Action Mailed
on September 18, 2025
(73 days)
Application History
9 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 18, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jun 18, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jun 18, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
Apr 1, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 31, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Mar 6, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
Mar 6, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Mar 6, 2025 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
Sep 25, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Chemical, biochemical, biological, biotechnological reagents, preparations and substances for laboratory use in the fields of life science, biotechnology and genomics; diagnostic and laboratory reagents, preparations and substances, for scientific use in the fields of life science, biotechnology and genomics; enzyme preparations for industrial purposes; enzymes for industrial purposes; industrial chemicals; biochemical catalysts; diagnostic preparations, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes; proteins for use in recombinant DNA technology, other than for medical use; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
Class 005
Chemicals for use in medical laboratories and/or for medical diagnostic purposes; therapeutic and diagnostic preparations and reagents for use in medical laboratories and/or for medical diagnostic purposes; biochemical, biological, biotechnological reagents, preparations and substances for use in medical laboratories and/or for medical diagnostic purposes; vaccine preparations; proteins for use in recombinant DNA technology for use in medical laboratories and/or for medical diagnostic purposes; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
Class 009
Scientific and laboratory apparatus, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acid research; apparatus, equipment and instruments for the detection and analysis of nucleic acids; kits containing apparatus, devices, instruments and equipment for measurement, analysis and quantification of chemical, biochemical and biological components for genomic and nucleic acids research; computer software applications, downloadable; material testing instruments and machines; testing apparatus not for medical purposes; diagnostic apparatus, not for medical purposes; chemistry apparatus and instruments; DNA chips; surveying apparatus and instruments; laboratory bioreactors; genetic testing apparatus for scientific use; laboratory apparatus for detecting genetic sequences; all of the aforesaid only to be used in the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
Class 042
Laboratory research services in the fields of life science, biotechnology and genomics; scientific research services in the fields of life science, biotechnology and genomics; biological, biotechnological, chemical and biochemical research, analysis and development services in the fields of life science, biotechnology and genomics; contract research services in the fields of life science, biotechnology and genomics; nucleic acids discovery, analysis and research and development services; nucleic acids and genomics research and development services for drugs and pharmaceutical discovery and research; nucleic acids production, processing and purification services; consultancy services relating to nucleic acids and genomics; research services for nucleic acids for therapeutic or diagnostic use; purification and production of nucleic acids for therapeutic or diagnostic use; design and manufacture of synthetic DNA, genes and oligonucleotides for others; genetic research; research and development services in the field of genomics; research and development services relating to vaccines and medicines; providing access to a proprietary technology platform containing non-viral nanoparticles; all of the aforesaid only to be used in connection to the manufacture and supply of synthetic DNA or RNA and targeted non-viral vectors for the delivery of nucleic acid payloads.
Active Deadlines
Non-Final Action E-Mailed
Due: Sep 18, 2025
Non-Final Action Mailed
Due: Sep 18, 2025
Classification
International Classes
001
005
009
042